Cross Talks Between Oxidative Stress, Inflammation and Epigenetics in Diabetic Retinopathy

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2023 Jan 21

PMID 36672234

Authors

Renu A Kowluru

Affiliations

Soon will be listed here.

Abstract

Diabetic retinopathy, one of the most devastating complications of diabetes, is a multifactorial progressing disease with a very complex etiology. Although many metabolic, molecular, functional and structural changes have been identified in the retina and its vasculature, the exact molecular mechanism of its pathogenesis still remains elusive. Sustained high-circulating glucose increases oxidative stress in the retina and also activates the inflammatory cascade. Free radicals increase inflammatory mediators, and inflammation can increase production of free radicals, suggesting a positive loop between them. In addition, diabetes also facilitates many epigenetic modifications that can influence transcription of a gene without changing the DNA sequence. Several genes associated with oxidative stress and inflammation in the pathogenesis of diabetic retinopathy are also influenced by epigenetic modifications. This review discusses cross-talks between oxidative stress, inflammation and epigenetics in diabetic retinopathy. Since epigenetic changes are influenced by external factors such as environment and lifestyle, and they can also be reversed, this opens up possibilities for new strategies to inhibit the development/progression of this sight-threatening disease.

Citing Articles

Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration.

Peng H, Hu Q, Zhang X, Huang J, Luo S, Zhang Y J Inflamm Res. 2025; 18:2205-2227.

PMID: 39968099 PMC: 11834741. DOI: 10.2147/JIR.S500214.

ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy.

Abu El-Asrar A, Nawaz M, Ahmad A, Siddiquei M, Allegaert E, Adyns L Cells. 2025; 14(2).

PMID: 39851513 PMC: 11764296. DOI: 10.3390/cells14020085.

Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline.

Lupu V, Miron I, Trandafir L, Jechel E, Starcea I, Ioniuc I Front Pharmacol. 2025; 15:1472670.

PMID: 39744134 PMC: 11688324. DOI: 10.3389/fphar.2024.1472670.

Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy.

Pelusi L, Hurst J, Detta N, Pipino C, Lamolinara A, Conte G Front Endocrinol (Lausanne). 2024; 15:1462043.

PMID: 39473506 PMC: 11518713. DOI: 10.3389/fendo.2024.1462043.

Association of the rs9896052 Polymorphism Upstream of with Proliferative Diabetic Retinopathy in Patients with Less than 10 Years of Diabetes.

Bastos C, da Silva Machado L, Crispim D, Canani L, Dos Santos K Int J Mol Sci. 2024; 25(19).

PMID: 39408563 PMC: 11477274. DOI: 10.3390/ijms251910232.

References

Kowluru A . Friendly, and not so friendly, roles of Rac1 in islet β-cell function: lessons learnt from pharmacological and molecular biological approaches. Biochem Pharmacol. 2011; 81(8):965-75. PMC: 3073707. DOI: 10.1016/j.bcp.2011.01.013. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Meleth A, Agron E, Chan C, Reed G, Arora K, Byrnes G . Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2005; 46(11):4295-301. DOI: 10.1167/iovs.04-1057. View

Kowluru R, Kowluru A, Veluthakal R, Mohammad G, Syed I, Santos J . TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy. Diabetologia. 2014; 57(5):1047-56. PMC: 10317023. DOI: 10.1007/s00125-014-3194-z. View

Kowluru R, Mohammad G . Epigenetics and Mitochondrial Stability in the Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy. Sci Rep. 2020; 10(1):6655. PMC: 7171070. DOI: 10.1038/s41598-020-63527-1. View

Szyf M, Meaney M . Epigenetics, behaviour, and health. Allergy Asthma Clin Immunol. 2010; 4(1):37-49. PMC: 2869339. DOI: 10.1186/1710-1492-4-1-37. View

Thomas A, Biswas S, Feng B, Chen S, Gonder J, Chakrabarti S . lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia. 2019; 62(3):517-530. DOI: 10.1007/s00125-018-4797-6. View

Zhuang P, Muraleedharan C, Xu S . Intraocular Delivery of miR-146 Inhibits Diabetes-Induced Retinal Functional Defects in Diabetic Rat Model. Invest Ophthalmol Vis Sci. 2017; 58(3):1646-1655. DOI: 10.1167/iovs.16-21223. View

Dong N, Xu B, Shi H . Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism. Inflamm Res. 2018; 67(11-12):913-925. DOI: 10.1007/s00011-018-1184-1. View

10.

Radhakrishnan R, Kowluru R . Long Noncoding RNA and Regulation of the Antioxidant Defense System in Diabetic Retinopathy. Diabetes. 2020; 70(1):227-239. PMC: 7881848. DOI: 10.2337/db20-0375. View

11.

Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A . Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med. 2009; 15(11):1298-306. PMC: 3290906. DOI: 10.1038/nm.2052. View

12.

Kowluru R, Zhong Q, Santos J . Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9. Expert Opin Investig Drugs. 2012; 21(6):797-805. PMC: 3802521. DOI: 10.1517/13543784.2012.681043. View

13.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

14.

Viswanath K, Murray McGavin D . Diabetic retinopathy: clinical findings and management. Community Eye Health. 2007; 16(46):21-4. PMC: 1705856. View

15.

Du J, Johnson L, Jacobsen S, Patel D . DNA methylation pathways and their crosstalk with histone methylation. Nat Rev Mol Cell Biol. 2015; 16(9):519-32. PMC: 4672940. DOI: 10.1038/nrm4043. View

16.

Duraisamy A, Mishra M, Kowluru A, Kowluru R . Epigenetics and Regulation of Oxidative Stress in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2018; 59(12):4831-4840. PMC: 6181189. DOI: 10.1167/iovs.18-24548. View

17.

Thomas A, Feng B, Chakrabarti S . ANRIL: A Regulator of VEGF in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017; 58(1):470-480. DOI: 10.1167/iovs.16-20569. View

18.

Black J, Van Rechem C, Whetstine J . Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012; 48(4):491-507. PMC: 3861058. DOI: 10.1016/j.molcel.2012.11.006. View

19.

Kolling M, Genschel C, Kaucsar T, Hubner A, Rong S, Schmitt R . Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury. Sci Rep. 2018; 8(1):3438. PMC: 5821887. DOI: 10.1038/s41598-018-21720-3. View

20.

Ma L, Cao J, Liu L, Du Q, Li Z, Zou D . LncBook: a curated knowledgebase of human long non-coding RNAs. Nucleic Acids Res. 2018; 47(D1):D128-D134. PMC: 6323930. DOI: 10.1093/nar/gky960. View